Evofem Biosciences Inc (NASDAQ:EVFM) Stock Continues to Fall: Down 12% in a Week

August 16, 2021

This past week, the Evofem Biosciences Inc (NASDAQ:EVFM) stock was in the middle of a strong selloff and ended the week with a decline of 12%. On Friday alone, the stock recorded a decline of 7%. It should be noted that last week the company had announced its financial results for the quarter and the six month period, both of which ended on June 30, 2021. The Chief Executive Officer…

Read More >>

Is Naked Brands Group (NASDAQ:NAKD) Stock a Buy Or Sell After The Recent Move?

August 16, 2021

Earlier on in the year, intimate apparel company Naked Brands Group (NASDAQ:NAKD) had emerged as one of the targets of retail traders from Reddit and the stock had made remarkable gains on the back of such action. However, at the same time, it should also be noted that most of the meme stocks are also beset with risks and it is no different when it comes to the Naked Brands…

Read More >>

MedX Holdings Inc (OTCMKTS:MEDH) Stock Sees Big Move: How To Trade Now?

August 16, 2021

MedX Holdings Inc (OTCMKTS:MEDH) jumped 40% after announcing an intent to acquire Dazed Inc. as its wholly-owned subsidiary. Dazed is a Texas-based company founded in 2007 with an operating history of more than 15 years in the cannabis sector, including related products. The Lazydaze brand formed in 2004 is better positioned for cannabis legalization ahead of the anticipated federal legalization. Currently, seven Dazed outlets include licensed, corporation-owned, and franchises and…

Read More >>

Herborium Group Inc. (OTCMKTS:HBRM) Stock Gains Momentum After The News: Are You Excited?

August 16, 2021

Herborium Group Inc. (OTCMKTS:HBRM) jumped 14% after announcing that its Q2 is marked by no share structure dilution and represents its fifth consecutive quarter since 2020 that it has been profitable. Additionally, Herborium’s margin was up 66%, with costs and expenses dropping 12% compared to the same period a year ago. To enhance more growth, the company is currently working in various corporate governance aspects that will benefit investors and…

Read More >>

SponsorsOne Inc (OTCMKTS:SPONF) Stock Retreats In Profit Booking: What Next?

August 16, 2021

SponsorsOne Inc (OTCMKTS:SPONF) fell 17% on Friday but up 18% for the past week. The company announced the signing of a distribution deal for Doc Wylder’s with Republic National Distributing Company. SponsorsOne CEO Myles Bartholomew stated that this is a massive milestone for the company to grow its distribution strategy as it seeks to reach leading national retailers. Myles explained that the ready-to-drink market is current among the rapidly growing…

Read More >>

Evoke Pharma Inc (NASDAQ:EVOK) Stock Sees Bullish Momentum After The News

August 16, 2021

Evoke Pharma Inc (NASDAQ:EVOK) jumped 20% after announcing its Q2 2021 financial results for the period ended June 30, 2021, including the latest corporate developments.CEO David Gonyer said that through the company’s ongoing commercial expansion, growing visibility in the gastroparesis community, and enhanced in-person physician access, they are motivated by the progress made in Q2 2021. He added that the company continued to witness promising trends in refills, prescribing physicians,…

Read More >>

Phunware Inc (NASDAQ:PHUN) Stock Falls Below $1: How to Trade Now?

August 16, 2021

Phunware Inc (NASDAQ:PHUN) dropped 15.5% as investors responded negatively to its Q2 2021 financial results. The company reported net revenue of $1.4 million thanks to the growth of the customer pipeline. Most of Phunware’s revenue was from subscriptions and services of the Multiscreen-as-a-Service platform, which generated revenue of $1.2 million. CEO Alan Knitowski stated that they are encouraged by the growing operational momentum the business saw in Q2 2021 despite…

Read More >>

Jaguar Health Inc (NASDAQ:JAGX) Stock Reports Quarterly Earnings: Stock Falls

August 16, 2021

Jaguar Health Inc (NASDAQ:JAGX) fell 6.75% after announcing its consolidated Q2 2021 financial results. During the quarter Mytesi, prescription volume was up 4.3% from Q1 2021, with net prescriptions increasing 2.8% over the same period. However, YoY prescription volume was down 9%, which the company attributes to the role of the pandemic leading to fewer patient visits, few refills, and fewer opportunities for Mytesi patients’ diagnosis. Mytesus net revenue was…

Read More >>

Acasti Pharma Inc (NASDAQ:ACST) Stock Falls After Earnings: Will The Trend Continue?

August 16, 2021

Acasti Pharma Inc (NASDAQ:ACST) fell 4.5% last week after announcing its fiscal Q1 2022 financial results for the period ended June 30, 2021, and provided a business update. The company posted a loss of $3.1 million or $0.01 on a per-share basis, a decrease from a net loss of $4.7 million or $0.05 per share a year ago. The net loss reduction resulted from reduced R&D expenses following the completion…

Read More >>

Venus Concept Inc (NASDAQ:VERO) Stock Continues to Move Lower: What Next?

August 16, 2021

Venus Concept Inc (NASDAQ:VERO) dropped 2% after announcing its Q2 2021 financial results for six months ending June 30, 2021. In Q2 2021, the company reported a 52% YoY revenue growth to $25.8 million with a gross margin of 72.5%. Adjusted EBITDA was 117% up YoY to $0.5 million. During the quarter, Health Canada issued the company a medical device license to sell the country’s Venus Fiore Feminine Health System….

Read More >>